Non-small cell lung cancer after surgery and chemoradiotherapy: follow-up and response assessment (original) (raw)
Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT
Zbigniew Podgajny
Pneumonologia i alergologia polska, 2013
View PDFchevron_right
Value of 18F-Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography/Computed Tomography in Non–Small-Cell Lung Cancer for Prediction of Pathologic Response and Times to Relapse after Neoadjuvant Chemoradiotherapy
Wilfried Eberhardt
Clinical Cancer Research, 2006
View PDFchevron_right
Comparing Two Imaging Methods for Follow-Up of Lung Cancer Treatment: A Randomized Pilot Study
Juerg Heuberger
The Annals of Thoracic Surgery, 2018
View PDFchevron_right
Prognostic Value of Postinduction Chemotherapy Volumetric PET/CT Parameters for Stage IIIA or IIIB Non–Small Cell Lung Cancer Patients Receiving Definitive Chemoradiotherapy
Wilfried Eberhardt
The Journal of Nuclear Medicine, 2021
View PDFchevron_right
FDG–PET in staging and restaging non-small cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology
Thomas Lynch
Lung Cancer, 2002
View PDFchevron_right
Diagnostic yield of baseline and follow-up PET/CT studies in ablative therapy for non-small cell lung cancer
Andres Serena
Revista Española de Medicina Nuclear e Imagen Molecular (English Edition), 2012
View PDFchevron_right
Areas of High 18F-FDG Uptake on Preradiotherapy PET/CT Identify Preferential Sites of Local Relapse After Chemoradiotherapy for Non-Small Cell Lung Cancer
Isabelle Gardin
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015
View PDFchevron_right
Prediction of Survival by [18F]Fluorodeoxyglucose Positron Emission Tomography in Patients With Locally Advanced Non-Small-Cell Lung Cancer Undergoing Definitive Chemoradiation Therapy: Results of the ACRIN 6668/RTOG 0235 Trial
Abass Alavi
Journal of Clinical Oncology, 2013
View PDFchevron_right
Monitoring and management of lung cancer patients following curative-intent treatment: clinical utility of 2-deoxy-2-[fluorine-18]fluoro-d-glucose positron emission tomography/computed tomography
Shigeki Sawada
Lung Cancer: Targets and Therapy, 2016
View PDFchevron_right
PET imaging for suspected residual tumour or thoracic recurrence of non-small cell lung cancer after pneumonectomy
Gavin Wright
Lung Cancer, 2005
View PDFchevron_right
Post-therapeutic positron emission tomography/computed tomography for early detection of non-small cell lung cancer recurrence
Thomas Henzler, Sonja Sudarski
Translational lung cancer research, 2013
View PDFchevron_right
18F-FDG PET for assessment of therapy response and preoperative re-evaluation after neoadjuvant radio-chemotherapy in stage III non-small cell lung cancer
Susanne Eschmann
European Journal of Nuclear Medicine and Molecular Imaging, 2007
View PDFchevron_right
Assessing the Usefulness of 18 F-fluorodeoxyglucose PET-CT Scan After Stereotactic Body Radiotherapy for Early-Stage Non-small Cell Lung Cancer
Travis Greer
Chest, 2014
View PDFchevron_right
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non–small cell lung cancer
Rathan Subramaniam
The Journal of Thoracic and Cardiovascular Surgery, 2013
View PDFchevron_right
Effect of PET/CT standardized uptake values on complete response to treatment before definitive chemoradiotherapy in stage III non-small cell lung cancer
Nalan Akgul Babacan
Clinical and Translational Oncology, 2018
View PDFchevron_right
Local failure after radical radiotherapy of non-small cell lung cancer in relation to the planning FDG-PET/CT
Lone Hoffmann
Acta Oncologica, 2017
View PDFchevron_right
Effectiveness of PET Scan in Postoperative Long Term Follow up of Patients with Nonsmall Cell Lung Cancer
Prof Dr Muzaffer Metin
Journal of Clinical and Analytical Medicine, 2012
View PDFchevron_right
Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer
Alan Herschtal
2014
View PDFchevron_right
High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer
Alan Herschtal, Michal Schneider-kolsky, Tomas Kron
Cancer, 2010
View PDFchevron_right
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer
Naoko Sanuki
Lung Cancer, 2013
View PDFchevron_right
18F-FLT PET/CT Adds Value to 18F-FDG PET/CT for Diagnosing Relapse After Definitive Radiotherapy in Patients with Lung Cancer: Results of a Prospective Clinical Trial
Helle Johannesen
Journal of Nuclear Medicine, 2020
View PDFchevron_right
Value of 18F FDG-PET/CT parameters on long term follow-up for patients with non-small cell lung cancer
Sergej Griff
Innovative Surgical Sciences
View PDFchevron_right
Comparative study between 18F-FDG PET scan and conventional CT in assessment of non-small cell lung cancer patients after treatment
Marina Hanna
International journal of health sciences, 2022
View PDFchevron_right
Follow-up with 18FDG-PET–CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: A prospective study
Michel Oellers
European Journal of Cancer, 2009
View PDFchevron_right
The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer
Alan Herschtal
Radiotherapy and Oncology, 2013
View PDFchevron_right
ICORG 06-35: a prospective evaluation of PET-CT scan in patients with non-operable or non-resectable non-small cell lung cancer treated by radical 3-dimensional conformal radiation therapy: a phase II study
Naomi Lavan
Irish Journal of Medical Science (1971 -), 2019
View PDFchevron_right
Diagnostic performance and prognostic impact of FDG-PET in suspected recurrence of surgically treated non-small cell lung cancer
Andreas Gröschel
European Journal of Nuclear Medicine and Molecular Imaging, 2006
View PDFchevron_right